Improving treatments for childhood nerve cancer means understanding its complexity
Once diagnosed, a child’s prospects of a successful recovery can vary considerably. The disease develops as low, intermediate or high risk depending on the aggressiveness of the tumour. This variability can make it difficult for doctors to assess each childs’ needs, and emphasises the importance of research into how different types of neuroblastoma respond to treatment. And a study published by a team of our scientists this week points to some possible answers.